Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Exp Mol Pathol. 2010 Apr 28;89(1):1–8. doi: 10.1016/j.yexmp.2010.04.001

Fig 4.

Fig 4

Proteasome chymotrypsin-like activity was measured in the Hepa 1–6 cells treated with PS-341 (a proteasome inhibitor) TNFa, IFNg and IFNg+TNFa. (SEM, N=3; Differences between all the groups: p= 0.047).